SCHEMBL14643137

SCHEMBL14643137

COC(=O)c1c(CNCl)c(=O)c2ccc(OC)cc2n1-c1ccccc1

nearest known ligand 0.75

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 20/20 0.75
MAPK9 P45984 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14643010 0.88 MAPK8 (0.78) MAPK8MAPK9
SCHEMBL14643009 0.88 MAPK8 (0.68) MAPK8MAPK9
SCHEMBL14617180 0.87 MAPK8 (0.72) MAPK8MAPK9
SCHEMBL14575606 0.87 MAPK8 (0.72) MAPK8MAPK9
Hydrochloric Acid SCHEMBL14576577 0.86 MAPK8 (0.71) MAPK8MAPK9
SCHEMBL14575850 0.86 MAPK8 (1.00) MAPK8
SCHEMBL14575822 0.85 MAPK8 (1.00) MAPK8
SCHEMBL15164771 0.84 MAPK8 (0.68) MAPK8MAPK9
SCHEMBL14575546 0.84 MAPK8 (1.00) MAPK8
SCHEMBL14575311 0.83 MAPK8 (1.00) MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501732-B2 Aminomethyl quinolone compounds HOFFMANN-LA ROCHE INC. (US) 2013-08-06 US disclosed
WO-2013007676-A1 AMINOMETHYL QUINOLONE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2013-01-17 WO disclosed
US-20130018043-A1 AMINOMETHYL QUINOLONE COMPOUNDS BILOTTA JOSEPH A (US) 2013-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018043-A1 AMINOMETHYL QUINOLONE COMPOUNDS MAP3K1, MAP3K11, MAP3K5 MAPK8 31/4885MAPK9 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.